Showing results (721-730 of 1,153) with videos related to
Sort By:
Pageof 116
Neurology|November 29, 2008
MRI in the diagnosis of pediatric multiple sclerosisD J A Callen, M M Shroff, H M Branson, et al.Pain|July 16, 2010
NMDA-receptor antagonist and morphine decrease CRPS-pain and cerebral pain representationS M Gustin, A Schwarz, N Birbaumer, et al.Journal of Leukocyte Biology|June 3, 2009
Low-dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethalityPinhua Pan, Jon Cardinal, Rajeev Dhupar, et al.Signal Transduction and Targeted Therapy|May 11, 2026
The evolving global landscape of first-in-class oncology drug innovationXiangyun Mao, Zhaoqing Wang, Shu Kong, et al.Cancer Gene Therapy|June 1, 1995
Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alphaK Nishihara, R F Barth, N Wilkie, et al.The Journal of Chemical Physics|December 3, 2015
Communication: Probing the absolute configuration of chiral molecules at aqueous interfacesStephan Lotze, Jan Versluis, Luuk L C Olijve, et al.The Annals of Thoracic Surgery|April 1, 2017
Targeting Immune Checkpoints in Esophageal Cancer: A High Mutational Load TumorRajeev Dhupar, Lauren Van Der Kraak, Arjun Pennathur, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 11, 2013
Patients with non-insulin depending diabetes mellitus and metabolic syndrome are suboptimal treated in Swiss primary careHans Hendrik Schäfer, Jacob Daniel de Villiers, Ulrich Lotze, et al.JACC. Cardiovascular Interventions|June 25, 2011
Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction)Holger Thiele, Ingo Eitel, Claudia Meinberg, et al.Stem Cells (Dayton, Ohio)|January 1, 1997
Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccinesJ I Mayordomo, T Zorina, W J Storkus, et al.Pageof 116